Skip to Content

673 P P (Cabergoline 0.5 mg)

Pill imprint 673 P P has been identified as Cabergoline 0.5 mg.

Cabergoline is used in the treatment of hyperprolactinemia and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Cabergoline 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Cabergoline 0.5 mg 673 P P
Cabergoline 0.5 mg 673 P P Front
Cabergoline 0.5 mg 673 P P Back
Cabergoline 0.5 mg 673 P P Front
Cabergoline 0.5 mg 673 P P Back
Cabergoline 0.5 mg 673 P P
Cabergoline
Imprint:
673 P P
Strength:
0.5 mg
Color:
White
Size:
7.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Prolactin inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Par Pharmaceutical Inc.
National Drug Code (NDC):
49884-0673
Inactive Ingredients:
citric acid
croscarmellose sodium
magnesium stearate
microcrystalline cellulose

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide